Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Elizabeth C. Smith"'
Autor:
Yushu Shi, Ann B. Nattinger, Joan M. Neuner, Sailaja Kamaraju, Elizabeth C. Smith, Purushottam W. Laud
Publikováno v:
Clinical Cardiology. 42:93-100
Background Theoretically, the estrogen deprivation induced by aromatase inhibitors (AIs) might cause ischemic heart disease, but empiric studies have shown mixed results. We aimed to compare AIs and tamoxifen with regard to cardiovascular events amon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb4a9b9c595600ccec96c0c5cd345869
https://doi.org/10.1002/clc.23114
https://doi.org/10.1002/clc.23114
Autor:
Luis, Balaguer, Fernando, Valladares, Carmen, Ascaso, Jeremy D, Barnes, Asuncion, DE Los Rios, Esteban, Manrique, Elizabeth C, Smith
Publikováno v:
The New phytologistreferences. 132(4)
Pormelia sulcata Taylor was used as a model to examine the effects of elevated CO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cc5809626cba5d844866143ffd32e471
https://pubmed.ncbi.nlm.nih.gov/33863134
https://pubmed.ncbi.nlm.nih.gov/33863134
Autor:
Hunter V Brigman, Cornelia B. Landersdorfer, Elizabeth C Smith, Christopher L. Emery, Jadyn C. Anderson, Elizabeth B. Hirsch, Phillip J. Bergen, Tiffany E. Bias
Publikováno v:
J Clin Microbiol
Fosfomycin has been shown to have a wide spectrum of activity against multidrug-resistant gram-negative bacteria; however, breakpoints have been established only for Escherichia coli or Enterobacterales per the Clinical and Laboratory Standards Insti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98ea892bc90c1ea60730f4a844c158a7
https://doi.org/10.1128/jcm.01121-20
https://doi.org/10.1128/jcm.01121-20
Publikováno v:
Journal of Clinical Microbiology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in December 2019 and has quickly become a worldwide pandemic. In response, many diagnostic manufacturers have developed molecular assays for SARS-CoV-2 under the Food a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0fce475118b2ad721b8e48d70349fa6
https://doi.org/10.1101/2020.05.14.097311
https://doi.org/10.1101/2020.05.14.097311
Autor:
Dina Zheng, Morgan L Bixby, Elizabeth C Smith, Jadyn C Anderson, Phillip J Bergen, Cornelia B Landersdorfer, Elizabeth B Hirsch
Publikováno v:
Open Forum Infectious Diseases
Background Fosfomycin combination therapy is a potential approach for treatment of multidrug-resistant (MDR) PA infections despite a lack of approved susceptibility breakpoints for this organism. While DD testing is commonly used for fosfomycin, grow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::689d5f70ef30d7b4fabbd642b59229d4
http://europepmc.org/articles/PMC8644777
http://europepmc.org/articles/PMC8644777
Autor:
Amanda L. Kong, John A. Charlson, Purushottam W. Laud, Alicia J. Smallwood, Joan M. Neuner, Sailaja Kamaraju, Elizabeth C. Smith, Yushu Shi
Publikováno v:
Journal of Cancer Survivorship. 12:268-275
Although users of aromatase inhibitors have higher total fracture risk in some randomized trials, little is known about their risk outside of clinical trials or in older higher-risk cohorts. In a population-based retrospective cohort study, we identi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::975fdbf5c83586fd18c78fb77695c59c
https://doi.org/10.1007/s11764-017-0666-4
https://doi.org/10.1007/s11764-017-0666-4
Autor:
Matthew P. Smeltzer, Meredith Ray, Raymond U. Osarogiagbon, Meghan Brooke Taylor, Denise McCoy, Sara Cat Williams, Jordan Goss Lane, Alicia Pacheco, Amanda Epperson, O. Akinbobola, Jeffrey Wright, Joy Luttrell, Todd Robbins, Kim Adams, Nicholas Faris, Carrie Fehnel, Elizabeth C. Smith, Wei Liao
Publikováno v:
Journal of Clinical Oncology. 39:13-13
13 Background: Early detection of lung cancer provides the best opportunity for long-term survival. In 2021 US Preventive Services Task Force (USPSTF) expanded the 2013 risk-based Low-dose CT (LDCT) screening criteria, in part to reduce unintended ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34918dd6c811782a44690630758269e3
https://doi.org/10.1200/jco.2020.39.28_suppl.13
https://doi.org/10.1200/jco.2020.39.28_suppl.13
Autor:
Jadyn C. Anderson, Elizabeth C Smith, Elizabeth B. Hirsch, Hunter V Brigman, Amanda R Krueger, Morgan L Bixby
Publikováno v:
Open Forum Infectious Diseases
Background FOF has been used in the treatment of multidrug-resistant (MDR) KP infections despite established susceptibility breakpoints. At present, agar dilution (AD) is considered the reference method for FOF while broth microdilution (BMD) is spec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0924535d0091e1e301d428420e5e86d4
http://europepmc.org/articles/PMC7777244
http://europepmc.org/articles/PMC7777244
Publikováno v:
Cancer Research. 77:PD4-07
Purpose: Aromatase Inhibitors (AIs) are the current standard of care for post-menopausal adjuvant endocrine breast cancer therapy either following or in place of tamoxifen. While their short-term side effect profile was favorable in most studies, fin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f928e3226ef3e245f70dab4916aa9dea
https://doi.org/10.1158/1538-7445.sabcs16-pd4-07
https://doi.org/10.1158/1538-7445.sabcs16-pd4-07
Publikováno v:
Cancer Research. 77:P5-16
Background: One of the benefits of neoadjuvant approach to the treatment of breast cancer is early microscopic disease control, which should translate to improved survival. However, clinical trials have not yet shown a survival benefit for neoadjuvan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d73ff3f8150ebbfce0edd563fed636e
https://doi.org/10.1158/1538-7445.sabcs16-p5-16-09
https://doi.org/10.1158/1538-7445.sabcs16-p5-16-09